emat

Buy Complete Report

Prix: €120 HT

Logo CreditCards Visa Logo CreditCards Mastercard

This report is accessible on EMAT, the reference database for private company acquisition multiples

 

 

► Subscribe to EMAT database

 

Sectors covered by our analysts

 

► Studies & indices published by Epsilon Research: Register to receive (free) publications updates

 

► Alert on reports published: Sign up (free) to receive by e-mail updates on EMAT reports published on your preferred sector.

 

Transaction Multiples for the Valuation of Private Companies

PRA International / Pharma Bio-Research Group

No EMAT : 16775
Announced Date : 19/06/2006
Type : Exit ,Acquisition of Majority Stake
Deal Value : Yes
Acquirer : PRA International

Target : Pharma Bio-Research Group
Country : Netherlands
Sector of activity :
  • Health, Pharmaceuticals & Biotechnology > Health Care Providers, Medical Equipment and Supplies
  • Health, Pharmaceuticals & Biotechnology > Biotechnology
Business Description :
Provides early-phase clinical trial management services > Provider of Phase I/IIA clinical trials and support services, including bioanalytical laboratory and data processing services to the...

Transaction multiples available
EV/
Sales
EV/
Gross Profit
EV/
EBITDA
EV/
EBIT
Eq/
PBT
P/E Price
to Book
Specific
multiple(s)
Historic ns
Current ns
Rating : ***
Multiple available
n.s.   Multiple calculated, but not significant

Source: Epsilon Research / EMAT

Comparable Transactions

  • Number of EMAT Reports / sub-sector « Health Care Providers, Medical Equipment and Supplies » = 719
  • Number of EMAT Reports / sub-sector « Biotechnology » = 43
Example of comparable transactions on EMAT (same sub-sector):
Date Acquirer Target Country Multiples See details
07/06/2006 Holding Sanita E Servizi HSS Residenze Anni Azzurri Italy ** 16766
01/04/2004 First Technology Envitec Wismar Germany *** 16472

Source: Epsilon Research / EMAT

About Epsilon Research

Epsilon Research is an independent research and financial analysis bureau, and the reference source of transaction multiples for the valuation of private companies through its EMAT database.

EMAT Report

► Each EMAT Report includes the detailed analysis of the transaction: deal rationale and structure, target business lines and financials (restated), valuation multiples (calculation and analysis).

 

► Example of EMAT Report